Compare DexCom, Inc. (DXCM) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs HP Inc — how do they compare? DexCom, Inc. trades at $77.1 (market cap $28.06B), while HP Inc trades at $24.02 (market cap $21.72B). The key difference: DexCom, Inc. is the larger of the two by market cap, and HP Inc pays a 5.05% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | HPQ | |
|---|---|---|
Market Cap | $28.06B | $21.72B |
Sector | Health | Technology |
52-Week High | $89.53 | $29.35 |
52-Week Low | $54.84 | $18.20 |
Enterprise Value | $27.03B | $28.88B |
Dividend Yield | — | 5.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
HPQ trades at $23.71, down 3.74% over 24 hours, with a bullish technical signal from moving averages and ADX indicators. Fundamentally, the stock shows value with a P/E of 8.8 and P/S of 0.39, supported by three consecutive quarterly EPS beats. Recent developments include a strategic partnership with OpenAI and a dividend yield near 5%, while cash flow trends improved to a net $460 million in 2025.
The outlook balances undervaluation and dividend appeal against PC market headwinds and negative equity. Risks include industry shipment declines and competitive pressure, but analyst consensus leans hold with a $22 price target, suggesting cautious optimism for AI-driven growth opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
